Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 2
2020 2
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression.
López-Tejada A, Griñán-Lisón C, González-González A, Cara FE, Luque RJ, Rosa-Garrido C, Blaya-Cánovas JL, Navarro-Ocón A, Valenzuela-Torres M, Parra-López M, Calahorra J, Blancas I, Marchal JA, Granados-Principal S. López-Tejada A, et al. Among authors: calahorra j. Int J Biol Sci. 2023 Jan 1;19(1):204-224. doi: 10.7150/ijbs.78738. eCollection 2023. Int J Biol Sci. 2023. PMID: 36594086 Free PMC article.
Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer.
Navarro-Ocón A, Blaya-Cánovas JL, López-Tejada A, Blancas I, Sánchez-Martín RM, Garrido MJ, Griñán-Lisón C, Calahorra J, Cara FE, Ruiz-Cabello F, Marchal JA, Aptsiauri N, Granados-Principal S. Navarro-Ocón A, et al. Among authors: calahorra j. Pharmaceutics. 2022 Feb 25;14(3):505. doi: 10.3390/pharmaceutics14030505. Pharmaceutics. 2022. PMID: 35335881 Free PMC article. Review.
Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells.
Calahorra J, Blaya-Cánovas JL, Castellini-Pérez O, Aparicio-Puerta E, Cives-Losada C, Marin JJG, Rementeria M, Cara FE, López-Tejada A, Griñán-Lisón C, Aulicino F, Berger I, Marchal JA, Delgado-Almenta V, Granados-Principal S. Calahorra J, et al. Biomed Pharmacother. 2024 Mar 21;174:116439. doi: 10.1016/j.biopha.2024.116439. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38518601 Free article.
Impact of hydroxytyrosol on stroke: tracking therapy response on neuroinflammation and cerebrovascular parameters using PET-MR imaging and on functional outcomes.
Barca C, Wiesmann M, Calahorra J, Wachsmuth L, Döring C, Foray C, Heiradi A, Hermann S, Peinado MÁ, Siles E, Faber C, Schäfers M, Kiliaan AJ, Jacobs AH, Zinnhardt B. Barca C, et al. Among authors: calahorra j. Theranostics. 2021 Feb 15;11(9):4030-4049. doi: 10.7150/thno.48110. eCollection 2021. Theranostics. 2021. PMID: 33754046 Free PMC article.
11 results